Biocon Biologics secures USFDA approval for biosimilar product to treat
ophthalmology conditions
Related Articles
-
Ethereum Spot ETF Hurdles: Expert Raises Concerns Over US SEC's ETH Security Review
As the cryptocurrency world anxiously awaits the decision regarding Ethereum Spot Exchange-Traded Funds (ETFs) from the United States Securities and Exchange Commission (SEC), much has been said about the variables that could influence the Commission’s ruling. Author and finance lawyer Scott Johnsson enters the discussion and highlights an important point: the SEC might consider Ethereum’s […]
-
Security Bite: Apple updates Platform Security guide with first-ever details on App Store security, BlastDoor, more
Apple this week updated its Platform Security guide, which contains in-depth technical information on security features implemented in its products. First released in 2015, the latest update adds six new topics, including first-ever details on BlastDoor 0-click protection and App Store security. 9to5Mac Security Bite is exclusively brought to you by Mosyle, the only Apple Unified Platform. Making Apple devices work-ready and enterprise-safe is all we do. Our unique integrated approach to...
-
Palo Alto Networks and IBM to Jointly Provide AI-powered Security Offerings; IBM to Deliver Security Consulting Services Across Palo Alto Networks Security Platforms
News Summary: IBM to platformize internal security solutions with Palo Alto Networks; Palo Alto Networks will be its preferred cybersecurity partner across network, cloud and SOC Palo Alto